Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1Phase 2 1Phase 1 1

Status

Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 43Breast 19Gynecologic 11Thoracic 9Sarcoma 9Head & Neck 9Genitourinary 9CNS 8Dermatologic 7Endocrine 3Tumor-Agnostic 2NET 1

Conditions

Pituitary Neoplasms 1Neuroendocrine Tumors 1Insulinoma 1

Interventions

Eating 5Standard of Care 4Radiofrequency Ablation 4Exercise 4Surgical Procedures, Operative 3Radiosurgery 3Endoscopic Mucosal Resection 3Adrenalectomy 3lutetium Lu 177 dotatate 2Yoga 2Saline Solution 2Robotic Surgical Procedures 2Resistance Training 2Proton Therapy 2Propofol 2Palliative Care 2Octreotide 2Magnetic Resonance Imaging 2Lutetium-177 2Liquid Biopsy 2Interviews as Topic 2Hydrocortisone 2Diet, Mediterranean 2Diet 2Desflurane 2Data Collection 2Conversion to Open Surgery 2Control Groups 2Calcium 23-Iodobenzylguanidine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Surgical Procedures, Operative × Endocrine × Clear all
NCT05735912 2026-01-13

ERASIN-RCT

Azienda Ospedaliera Universitaria Integrata Verona

Phase NA Active not recruiting
60 enrolled
Endocrine

Insulinoma

NCT03012789 2024-04-30

NETest_Sx

Wren Laboratories LLC

Phase NA Active not recruiting
40 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03714763 2018-10-22

Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)

Ruijin Hospital

Phase NA Unknown
50 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡